XML 26 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock Appreciation Rights, Deferred Compensation and Redeemable Noncontrolling Interests
9 Months Ended
Jan. 31, 2019
Stock Appreciation Rights, Deferred Compensation and Redeemable Noncontrolling Interests  
Stock Appreciation Rights, Deferred Compensation and Redeemable Noncontrolling Interests

9. Stock Appreciation Rights, Deferred Compensation and Redeemable Noncontrolling Interests

The following table presents a summary of changes to the liabilities for stock appreciation rights, deferred compensation and redeemable noncontrolling interests for the nine months ended January 31, 2019:

 

 

 

 

 

 

 

 

 

 

 

 

Stock

 

 

 

 

Redeemable

 

 

Appreciation

 

Deferred

 

Noncontrolling

 

    

Rights

    

Compensation

    

Interests

 

 

(in thousands)

Balance as of April 30, 2018

 

$

21,944

 

$

2,222

 

$

16,170

Amounts redeemed

 

 

(1,216)

 

 

(715)

 

 

(4,673)

Change in fair value

 

 

1,426

 

 

118

 

 

661

Balance as of January 31, 2019

 

$

22,154

 

$

1,625

 

$

12,158

 

 

 

 

 

 

 

 

 

 

Classified as current as of April 30, 2018

 

$

308

 

$

133

 

$

463

Classified as long-term as of April 30, 2018

 

 

21,636

 

 

2,089

 

 

15,707

 

 

 

 

 

 

 

 

 

 

Classified as current as of January 31, 2019

 

$

981

 

$

 —

 

$

1,034

Classified as long-term as of January 31, 2019

 

 

21,173

 

 

1,625

 

 

11,124

 

Total expense related to these instruments was $2.2 million and $3.2 million during the nine months ended January 31, 2019 and 2018, respectively, and was included in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations and Comprehensive Income.

Stock Appreciation Rights

Certain subsidiaries have granted stock appreciation rights to certain employees under which payments are dependent on the appreciation in the book value per share, adjusted for certain provisions, of the applicable subsidiary. Settlements of the awards can be made in a combination of cash or installment notes, generally paid over four years, upon a triggering event. As of January 31, 2019, all stock appreciation rights were vested.

Deferred Compensation

Subsidiaries’ stockholders have entered into other deferred compensation agreements that granted the stockholders a payment based on a percentage in excess of book value, adjusted for certain provisions, upon an occurrence as defined in the related agreements, which are called “Buy Sell” agreements. These instruments are redeemed in cash or installment notes, generally paid in annual installments over the five years following termination of employment.

Redeemable Noncontrolling Interests

Noncontrolling interests were issued to certain employees of the subsidiaries. All of the noncontrolling interest awards are subject to mandatory redemption on termination of employment for any reason. These instruments are redeemed in cash or installment notes, generally paid in annual installments over the five years following termination of employment. Liabilities related to these agreements are classified as share-based liability awards and are measured at intrinsic value. Intrinsic value is determined to be the stated redemption value of the shares. Under the terms of the employee agreements, the redemption value is determined based on the book value of the subsidiary, as adjusted for certain items.

Upon the termination of employment or other triggering events including death or disability of the noncontrolling stockholders in the Company’s subsidiaries, we are obligated to purchase, or redeem, the noncontrolling interests at either an agreed upon price or a formula value provided in the stockholder agreements. This formula value is typically based on the book value per share of the subsidiary’s equity, including certain adjustments.